{"id":"NCT03197376","sponsor":"PATH","briefTitle":"Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants","officialTitle":"A Phase 3, Randomized, Double-Blind Study of the Safety, Tolerability, Lot-to-Lot Consistency, Immunogenicity & Non-Interference With Concomitant Vaccinations of Serum Institute of PNEUMOSIL in Healthy Infants in The Gambia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-06-21","primaryCompletion":"2018-06-06","completion":"2019-05-09","firstPosted":"2017-06-23","resultsPosted":"2019-09-11","lastUpdate":"2020-07-14"},"enrollment":2250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumonia, Pneumococcal"],"interventions":[{"type":"BIOLOGICAL","name":"Pneumosil","otherNames":[]},{"type":"BIOLOGICAL","name":"Synflorix","otherNames":[]}],"arms":[{"label":"Pneumosil Lot 1","type":"EXPERIMENTAL"},{"label":"Pneumosil Lot 2","type":"EXPERIMENTAL"},{"label":"Pneumosil Lot 3","type":"EXPERIMENTAL"},{"label":"Synflorix","type":"ACTIVE_COMPARATOR"}],"summary":"This study will examine the consistency of 3 batches of the Pneumosil vaccine by looking at the immune response in infants. In addition, the study will compare the immunogenicity of the Pneumosil vaccine to another WHO-prequalified vaccine, Synflorix.","primaryOutcome":{"measure":"Serotype-specific Geometric Mean Concentration of IgG Antibody","timeFrame":"4 weeks after the third dose","effectByArm":[{"arm":"Lot 1","deltaMin":4.08,"sd":null},{"arm":"Lot 2","deltaMin":4.24,"sd":null},{"arm":"Lot 3","deltaMin":4.58,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"6 Weeks","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":1,"countries":["The Gambia"]},"refs":{"pmids":["33516293"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":51,"n":1503},"commonTop":["Upper respiratory tract infection","Diarrhoea","Gastroenteritis","Furuncle","Conjunctivitis"]}}